Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calpains are a family of intracellular, calcium-dependent, non-lysosomal cysteine proteases. They are ubiquitously expressed in mammals and many other organisms, playing key roles in various cellular processes by mediating limited proteolysis of specific substrates. The calpain system includes the calpain proteases themselves, a small regulatory subunit (CAPNS1/CAPN4), and an endogenous inhibitor called calpastatin. Dysregulation or overactivation has been implicated as an aggravating factor in various diseases including neurodegeneration after trauma/stroke/myocardial infarction due to excessive substrate cleavage following abnormal increases in intracellular Ca²⁺ levels.
Calpain inhibitors (being developed) aim to reduce excessive proteolysis following calcium dysregulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calpain.